KYMERA THERAPEUTICS, INC. (KYMR) Return on equity 2020–2025
KYMERA THERAPEUTICS, INC. (KYMR) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
19.7%FY2025 · since FY2020: -16.1% → 19.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 19.7% | -7.1 pp |
| FY2024 | 26.8% | -10.4 pp |
| FY2023 | 37.2% | +5.6 pp |
| FY2022 | 31.6% | +9.8 pp |
| FY2021 | 21.8% | +37.9 pp |
| FY2020 | -16.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice